Evidence map›Paper›PMID 28588969›Full record

ArticleBMJ global health2016

It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North-South collaborative trials.

Raffaella Ravinetto, Halidou Tinto, Ermias Diro, Joseph Okebe, Yodi Mahendradhata, Suman Rijal, Eduardo Gotuzzo, Pascal Lutumba, Alain Nahum, Katelijne De Nys and 2 more

Abstract read
In one paragraph

Article in BMJ global health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Collaboration Benefits All.JCO global oncology · 2020
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Raffaella RavinettoPublic Health Department, Institute Tropical Medicine, Antwerp, Belgium.
Halidou TintoClinical Research Unit Nanoro, Nanoro, Burkina Faso.
Ermias DiroDepartment of Internal Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Joseph OkebeMedical Research Council Unit, The Gambia, Fajara, Gambia.
Yodi MahendradhataFaculty of Medicine, Center for Tropical Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Suman RijalB.P. Koirala Institute of Health Science, Dharan, Nepal.
Eduardo GotuzzoDepartment of Medicine, Alexander von Humboldt Institute of Tropical Medicine and Infectious Diseases, Lima, Peru.
Pascal LutumbaUniversity of Kinshasa, Kinshasa, Democratic Republic of Congo.
Alain NahumCentre des Recherches Entomologiques de Cotonou, Cotonou, Benin.
Katelijne De NysClinical Trial Center, Leuven University Hospital, KU Leuven, Leuven, Belgium.
Minne CasteelsDepartment of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Marleen BoelaertPublic Health Department, Institute Tropical Medicine, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Good Clinical Practices (GCP) codes of the WHO and the International Conference of Harmonization set international standards for clinical research. But critics argue that they were written without consideration for the challenges faced in low and middle income countries (LMICs). Based on our field experience in LMICs, we developed a non-exhaustive set of recommendations for the improvement of GCP. These cover 3 domains: ethical, legal and operational, and 8 specific issues: the double ethical review of 'externally sponsored' trials; the informed consent procedure in minors and in illiterate people; post-trial access to newly-developed products for the trial communities; the role of communities as key research actors; the definition of sponsor; and the guidance for contractual agreements, laboratory quality management systems, and quality assurance of investigational medicinal products. Issues not covered in our analysis include among others biobanking, standard of care, and study designs. The international GCP codes

Identifiers

PMID28588969
PMCPMC5321366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.